Page 232 - எங்களுக்கு தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Grant County child recovering from county s first case of MIS-C
krem.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from krem.com Daily Mail and Mail on Sunday newspapers.
One size doesn t fit all when it comes to products for preventing HIV from anal sex
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
5 Mar 2021
LONDON (AP) – Regulators in the UK and four other countries have announced new rules to fast-track the development of modified COVID-19 vaccines to ensure drugmakers can move swiftly to target emerging variants of the disease.
Previously authorized vaccines that are modified to combat new variants “will not need a brand new approval or `lengthy’ clinical studies,” Britain’s Medicines and Healthcare Products Regulatory Agency said Thursday.
“The clear goal is that future vaccine modifications that respond to the new variants of coronavirus can be made available in the shortest possible time to UK recipients without compromising at any stage on safety, quality or effectiveness,” Dr June Raine, the head of the agency, said in a briefing for reporters.
UK, 4 nations fast-track review of modified COVID vaccines
By The Associated Press - | Mar 5, 2021
Doctor Anil Mehta, surrounded by his team of doctors, administers a dose of the Pfizer vaccine to Geeta Waddon to mark the 10,000th jab in his small practice in London, Sunday, Feb. 28, 2021. (AP Photo/Frank Augstein)
LONDON (AP) Regulators in the U.K. and four other countries have announced new rules to fast-track the development of modified COVID-19 vaccines to ensure drugmakers can move swiftly to target emerging variants of the disease.
Previously authorized vaccines that are modified to combat new variants “will not need a brand new approval or ‘lengthy’ clinical studies,” Britain’s Medicines and Healthcare Products Regulatory Agency said Thursday.
GSK, Vir halt enrolment of phase 3 COVID-19 antibody study
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.